Pulmonary nocardiosis: Risk factors and outcomes

Respirology

Volumn 12, Issue 3, 2007, Pages 394-400

  Martínez Tomás, Raquel ^a   Menéndez Villanueva, Rosario ^a   Reyes Calzada, Soledad ^a   Santos Durantez, Maruja ^b   Vallés Tarazona, José Manuel ^a   Modesto Alapont, Manuel ^a   Gobernado Serrano, Miguel ^b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Mortality; Nocardia; Outcome; Pneumonia; Risk factor

Indexed keywords

BECLOMETASONE; CORTICOSTEROID; DEFLAZACORT; DEXAMETHASONE; METHYLPREDNISOLONE; PREDNISONE; STEROID; ANTIINFECTIVE AGENT; IMMUNOSUPPRESSIVE AGENT; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADULT; ALCOHOLISM; ARTICLE; CENTRAL NERVOUS SYSTEM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG INFECTION; LUNG NOCARDIOSIS; MALE; MORTALITY; PRIORITY JOURNAL; RESPIRATORY SYSTEM; RISK FACTOR; TRANSPLANTATION; AGED; DRUG EFFECT; LUNG; LUNG DISEASE; MICROBIOLOGY; MIDDLE AGED; NOCARDIA; NOCARDIOSIS; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; PATHOGENICITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-INFECTIVE AGENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; NOCARDIA; NOCARDIA INFECTIONS; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS; SULFAMETHOXAZOLE; TREATMENT OUTCOME; TRIMETHOPRIM;

EID: 34547477157     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2007.01078.x     Document Type: Article

References (38)

1. Sorrell TC, Mitchell DH, Iredell JR. Nocardia species. In : Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases, 6th edn. Churchill Livingstone, USA, 2005 2916 24.
2. Saubolle MA, Sussland D. Nocardiosis: review of clinical and laboratory experience. J. Clin. Microbiol. 2003 41 : 4497 501.
3. Beaman BL, Burnside J, Edwards B, Causey W. Nocardial infections in the United States, 1972-1974. J. Infect. Dis. 1976 134 : 286 9.
4. Laurent F, Mick V, Boiron P. Nocardia infections: clinical and biological aspects. Ann. Biol. Clin. 1999 57 : 545 54.
5. Beaman BL, Beaman L. Nocardia species: host-parasite relationships. Clin. Microbiol. Rev. 1994 7 : 213 64.
6. Menéndez R, Cordero PJ, Santos M, Gobernado M, Marco V. Pulmonary infection with Nocardia species: a report of 10 cases and review. Eur. Respir. J. 1997 10 : 1542 6.
7. National Committee for Clinical Laboratory Standards. Susceptibility Testing of Mycobacteria, Nocardia, and Other Aerobic Actinomycetes. Approved Standard NCCLS document M24-A, 2003.
8. Palmer DL, Harvey RL, Wheeler JK. Diagnostic and therapeutic considerations in Nocardia asteroides infection. Medicine 1974 53 : 391 401.
9. Berkey P, Bodey GP. Nocardial infection in patients with neoplastic disease. Rev. Infect. Dis. 1989 11 : 407 12.
10. Uttamchandani RB, Daikos GL, Reyes RR, Fischl MA, Dickinson GM, et al. Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcome. Clin. Infect. Dis. 1994 18 : 348 53.
11. Rosett W, Hodges GR. Recent experiences with nocardial infections. Am. J. Med. Sci. 1978 276 : 279 85.
12. Black CM, Beaman BL, Donnovan RM, Goldstein E. Effect of virulent and less virulent strains of Nocardia asteroides on acid-phosphatase activity in alveolar and peritoneal macrophages maintained in vitro. J. Infect. Dis. 1983 148 : 117 24.
13. Peaboy JW, Seabury JH. Actinomycosis and nocardiosis. Am. J. Med. 1960 28 : 99 115.
14. Simpson GL, Stinson EB, Egger MJ, Remington JS. Nocardial infections in the immunocompromised host: a detailed study in a defined population. Rev. Infect. Dis. 1981 3 : 492 507.
15. Wilson JP, Turner HR, Kirchner KA, Chapman SW. Nocardial infections in renal transplant recipients. Medicine 1989 68 : 38 57.
16. Keating MR, Wilhelm MP, Walker RC. Strategies for prevention of infection after cardiac transplantation. Mayo Clin. Proc. 1992 67 : 676 84.
17. Choucino C, Goodman SA, Greer JP, Stein RS, Wolff SN, et al. Nocardial infections in bone marrow recipients. Clin. Infect. Dis. 1996 23 : 1012 19.
18. Husain S, McCurry K, Dauber J, Singh N, Kusne S. Nocardia infection in lung transplant recipients. J. Heart Lung Transplant. 2002 21 : 354 9.
19. Lerner PI. Nocardiosis. Clin. Infect. Dis. 1996 22 : 891 905.
20. Betriu C. Infections by Nocardia. Enferm. Infect. Microbiol. Clin. 1997 15 : 154 60.
21. Grossman CB, Bragg DG, Armstrong D. Roentgen manifestation of pulmonary nocardiosis. Radiology 1970 96 : 325 30.
22. Kramer MR, Uttamchandani RB. The radiographic appearance of pulmonary nocardiosis associated with AIDS. Chest 1990 98 : 382 5.
23. Menéndez R, Perpiñá M, Torres A. Evaluation of nonresolving and progressive pneumonia. Semin. Respir. Infect. 2003 18 : 103 11.
24. Pintado V, Gómez-Mampaso E, Fotún J, Meseguer MA, Cobo J, et al. Infection with Nocardia species: clinical spectrum of disease and species distribution in Madrid, Spain, 1978-2001. Infection 2002 30 : 338 40.
25. Filice GA. Nocardiosis. In : Niederman MS, Sarosi GA, Glassroth J (eds). Respiratory Infections, 2nd edn. Lippincott Williams and Wilkins, Philadelphia, PA, 2001 457 66.
26. Smego RA Jr, Moeller MB, Gallis HA. Trimethoprim-sulfamethoxazole therapy for Nocardia infections. Arch. Intern. Med. 1983 143 : 711 18.
27. McNeil MM, Brown JM. The medically important aerobic actinomycetes epidemiology and microbiology. Clin. Microbiol. Rev. 1994 7 : 357 417.
28. McNeil MM, Brown JM, Hutwagner LC, Schiff TA. Evaluation of therapy for Nocardia asteroides complex infections. Infect. Dis. Clin. Pract. 1995 4 : 287 92.
29. Gombert ME, Aulicino TM. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides. Antimicrob. Agents Chemother. 1983 24 : 810 11.
30. Gombert ME, Aulicino TM, DuBouchet L, Silverman GE, Sheinbaum WM. Therapy of experimental cerebral nocardiosis with imipenem, amikacin, trimethoprim-sulfamethoxazol, and minocycline. Antimicrob. Agents Chemother. 1986 30 : 270 3.
31. Mensa J, Gatell JM, Jimenez de Anta MT, Prats G, Domínguez-Gil A. Guía Terapéutica Antimicrobiana. Masson, Barcelona, Spain, 2003.
32. Gilbert DN, Moellering RC, Eliopoulos GM, Sande MA. The Sanford Guide to Antimicrobial Therapy. Antimicrobial Therapy, Inc., Sperryville, EEUU, 2006.
33. Cunha BA. Antibiotics Essentials. Physicians Press, Royal Oak, MI, 2004.
34. Runyon EH. Nocardia asteroides: studies of its pathogenicity and drug sensitivities. J. Lab. Clin. Med. 1951 37 : 713 25.
35. Khardori N, Shawar R, Gupta R, Rosenbaum B, Rolston K. In vitro antimicrobial susceptibilities of Nocardia species. Antimicrob. Agents. Chemother. 1993 37 : 882 4.
36. Mari B, Montón C, Mariscal D, Lujan M, Sala M, et al. Pulmonary nocardiosis: clinical experience in ten cases. Respiration 2001 68 : 382 8.
37. Hui CH, Au VWK, Rowland K, Slavotinek JP, Gordon DL. Pulmonary nocardiosis re-visited: experience of 35 patients at diagnosis. Respir. Med. 2003 97 : 709 17.
38. Burgert SJ. Nocardiosis: a clinical review. Infect. Dis. Clin. Pract. 1999 8 : 27 32.